Merck & Co (MRK)

148.35
-1.19 (-0.80%)
NYSE· Last Trade: Aug 29th, 11:53 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close149.54
Open146.72
Bid148.01
Ask149.54
Day's Range145.75 - 149.01
52 Week Range77.58 - 156.92
Volume8,067,849
Market Cap375.53B
PE Ratio (TTM)20.35
EPS (TTM)7.3
Dividend & Yield3.400 (2.29%)
1 Month Average Volume10,818,432

Chart

About Merck & Co (MRK)

Merck & Co is a global healthcare company that specializes in the development, manufacturing, and marketing of pharmaceutical products and vaccines. The company is dedicated to improving health outcomes through innovative research and is known for its focus on areas such as oncology, infectious diseases, and immunology. In addition to its pharmaceutical offerings, Merck actively engages in the discovery of new biologics and therapies, working to address some of the most pressing health challenges worldwide. Through its commitment to scientific excellence and patient care, Merck plays a critical role in advancing public health and enhancing quality of life globally. Read More

News & Press Releases

What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · August 28, 2026
Stay informed with the top movers within the dow jones index on Friday.chartmill.com
Via Chartmill · August 28, 2026
Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.fool.com
Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.
Via The Motley Fool · August 28, 2026
What's going on in today's after hours session: S&P500 moverschartmill.com
Via Chartmill · August 27, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · August 27, 2026
Thursday's session: top gainers and losers in the dow jones indexchartmill.com
Via Chartmill · August 27, 2026
Exploring the top movers within the dow jones index during today's session.chartmill.com
Via Chartmill · August 27, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · August 26, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · August 26, 2026
These dow jones stocks are moving in today's sessionchartmill.com
Via Chartmill · August 25, 2026
Top dow jones movers in Tuesday's sessionchartmill.com
Via Chartmill · August 25, 2026
Exploring the top movers within the dow jones index during today's session.chartmill.com
Via Chartmill · August 24, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · August 24, 2026
Why Tempus AI Skyrocketed This Weekfool.com
Tempus AI's latest acquisition is looking like a great move.
Via The Motley Fool · August 23, 2026
2 Biotech Stocks Shaping Up for Major Breakoutsmarketbeat.com
Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.
Via MarketBeat · August 22, 2026
MarketBeat Week in Review – 08/17 - 08/21marketbeat.com
Stocks fell this week as Treasury bond buybacks, oil prices, and Walmart earnings weighed on markets, while Bitcoin rallied; MarketBeat analysts cover Moderna, NVIDIA, Meta, RTX, and more.
Via MarketBeat · August 22, 2026
Discover which dow jones stocks are making waves on Friday.chartmill.com
Via Chartmill · August 21, 2026
Stay informed with the top movers within the dow jones index on Friday.chartmill.com
Via Chartmill · August 21, 2026
Moderna’s 177% Surge Has Investors Asking What Comes Nextmarketbeat.com
Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.
Via MarketBeat · August 21, 2026
Walmart's Guide-Down Sinks the Dow as Trump Readies an "Economic D-Day" for Iranchartmill.com
Via Chartmill · August 21, 2026
Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Aheadmodernas-com
Breaking news: Moderna isn't just a "pandemic stock" after all.
Via The Motley Fool · August 20, 2026
Moderna Doubles on Melanoma Vaccine Win, Treasury Steps In to Cap Long-End Yieldschartmill.com
Via Chartmill · August 20, 2026
Why Moderna Stock Skyrocketed Todayfool.com
The biotech could be on the verge of setting a new standard of care for skin cancer.
Via The Motley Fool · August 19, 2026
Which dow jones stocks are moving on Wednesday?chartmill.com
Via Chartmill · August 19, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · August 19, 2026